Exact Mass: 293.0688046
Exact Mass Matches: 293.0688046
Found 52 metabolites which its exact mass value is equals to given mass value 293.0688046,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Lumiracoxib
C15H13ClFNO2 (293.06188000000003)
Lumiracoxib is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug. On August 11, 2007, Australias Therapeutic Goods Administration (TGA, the Australian equivalent of the FDA) cancelled the registration of lumiracoxib in Australia due to concerns that it may cause liver failure. New Zealand and Canada have also followed suit in recalling the drug. M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AH - Coxibs D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents
3G8CFM4T9A
Aristololactam is a natural product found in Aristolochia tubiflora, Aristolochia argentina, and other organisms with data available. Aristololactam I (AL-I), is the main metabolite of aristolochic acid I (AA-I), participates in the processes that lead to renal damage. Aristololactam I (AL-I) directly injures renal proximal tubule cells, the cytotoxic potency of AL-I is higher than that of AA-I and that the cytotoxic effects of these molecules are mediated through the induction of apoptosis in a caspase-3-dependent pathway[1]. Aristololactam I (AL-I), is the main metabolite of aristolochic acid I (AA-I), participates in the processes that lead to renal damage. Aristololactam I (AL-I) directly injures renal proximal tubule cells, the cytotoxic potency of AL-I is higher than that of AA-I and that the cytotoxic effects of these molecules are mediated through the induction of apoptosis in a caspase-3-dependent pathway[1].
Noraristolodione
Noraristolodione is a natural product found in Aristolochia elegans, Aristolochia indica, and other organisms with data available.
Lumiracoxib
C15H13ClFNO2 (293.06188000000003)
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AH - Coxibs D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents
2-AMINO-4-(3,4-DIMETHOXYPHENYL)THIOPHENE-3-CARBOXYLICACIDMETHYLESTER
Benserazide hydrochloride
C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C471 - Enzyme Inhibitor
5-tert-butoxycarbonylamino-benzo[b]thiophene-2-carboxylic acid
ETHYL 2-(3,4-DIMETHOXYPHENYL)THIAZOLE-4-CARBOXYLATE
[3-Acetyl-2-(4-fluoro-phenyl)-4-hydroxy-5-oxo-2,5-dihydro-pyrrol-1-yl]-acetic acid
1-(1-ADAMANTYL)-2-BROMOPROPAN-1-ONE
C15H20BrN (293.07790200000005)
1-(3-MORPHOLINOPROPYL)PIPERAZINE
C11H17Cl2N3O2 (293.06977620000004)
5(4H)-Oxazolone,4-(1,3-benzodioxol-5-ylmethylene)-2-phenyl-
1-(2-NAPHTHALENYL)-1H-PYRROLE-2,5-DIONE
C11H17Cl2N3O2 (293.06977620000004)